科微学术

微生物学通报

猪链球菌2型PPCDC蛋白对血脑屏障通透性的影响
作者:
基金项目:

国家重点研发计划(2021FYD1800405)


Streptococcus suis type 2 PPCDC protein affects permeability of blood-brain barrier
Author:
  • 摘要
  • | |
  • 访问统计
  • |
  • 参考文献 [27]
  • |
  • 相似文献 [20]
  • | | |
  • 文章评论
    摘要:

    【背景】猪链球菌2型(Streptococcus suis type 2, SS2)是引起全球经济和公共卫生问题的重要人兽共患病病原菌,引发脑膜炎、关节炎和败血症等临床症状。磷酸泛酰半胱氨酸脱羧酶(phosphopantothenoylcyteine decarboxylase, PPCDC)在前期构建的猪体外血脑屏障模型与猪链球菌全基因组噬菌体随机展示文库的相互作用中被筛选出来,但其影响血脑屏障的机制尚不清楚。【目的】探究PPCDC在SS2诱导脑膜炎过程中发挥的作用。【方法】利用大肠杆菌(Escherichia coli)表达系统诱导表达重组蛋白rPPCDC,通过体外构建人脑微血管内皮细胞单层屏障模型和体内小鼠感染模型探究其对血脑屏障通透性的影响,制备rPPCDC疫苗进行小鼠免疫保护试验。【结果】成功纯化出可溶性重组蛋白rPPCDC,发现其在体外可以降低单层屏障模型的细胞跨膜电阻值,增加突破单层屏障的SS2数量。体内可促进SS2对小鼠的致病性。进一步研究发现,接种rPPCDC疫苗的小鼠血清中有更高的rPPCDC抗体水平,存活率升高。【结论】PPCDC能够增强血脑屏障通透性,促进SS2对小鼠血脑屏障的破坏和脑部感染,并具有免疫保护效力,为后续SS2致病机制研究和疫苗研发提供新思路。

    Abstract:

    [Background] Streptococcus suis type 2 (SS2) is a major zoonotic pathogen leading to global economic and public health problems, causing meningitis, arthritis, and sepsis. Phosphopantothenoylcysteine decarboxylase (PPCDC) was screened out in the previous study about the interaction between the porcine blood-brain barrier model in vitro and S. suis genome-wide phage display random library, while the mechanism of PPCDC in affecting the blood-brain barrier remains unclear. [Objective] To explore the role of PPCDC in the SS2-induced meningitis. [Methods] In this study, the recombinant protein rPPCDC was expressed in Escherichia coli. The monolayer barrier model of human brain microvascular endothelial cells in vitro and the mouse infection model in vivo were established to study the effect of rPPCDC on the permeability of blood-brain barrier. Furthermore, the rPPCDC vaccine was prepared for the immunoprotection test in mice. [Results] The soluble recombinant protein rPPCDC was successfully purified. This protein reduced the transmembrane resistance of cells in the monolayer barrier model, increased the number of SS2 breaking through the monolayer barrier in vitro. In addition, the protein enhanced the pathogenicity of SS2 in mice. The mice vaccinated with rPPCDC had higher serum levels of rPPCDC antibodies and increased survival. [Conclusion] PPCDC can enhance the permeability of blood-brain barrier and promote the destruction of blood-brain barrier and brain infection of SS2 in mice, thus exerting the immunoprotective effect. The findings provide new ideas for the future research on the pathogenic mechanism of SS2 and the development of vaccines.

    参考文献
    [1] VÖTSCH D, WILLENBORG M, WELDEAREGAY YB, VALENTIN-WEIGAND P. Streptococcus suis-the two faces of a pathobiont in the porcine respiratory tract[J]. Frontiers in Microbiology, 2018, 9: 480.
    [2] ZHU JL, WANG JP, KANG WM, ZHANG XY, KERDSIN A, YAO HC, ZHENG H, WU ZF. Streptococcus suis serotype 4: a population with the potential pathogenicity in humans and pigs[J]. Emerging Microbes & Infections, 2024, 13(1): 2352435-2352435.
    [3] Bleuzé M, Gottschalk M, Segura M. Neutrophils in Streptococcus suis infection: from host defense to pathology[J]. Microorganisms, 2021, 9(11): 2392.
    [4] HAAS B, GRENIER D. Understanding the virulence of Streptococcus suis: a veterinary, medical, and economic challenge[J]. Médecine et Maladies Infectieuses, 2018, 48(3): 159-166.
    [5] ROODSANT TJ, van der ARK KCH, SCHULTSZ C. Translocation across a human enteroid monolayer by zoonotic Streptococcus suis correlates with the presence of Gb3-positive cells[J]. iScience, 2024, 27(3): 109178.
    [6] FENG YJ, ZHANG HM, WU ZW, WANG SH, CAO M, HU D, WANG CJ. Streptococcus suis infection: an emerging/reemerging challenge of bacterial infectious diseases?[J]. Virulence, 2014, 5(4): 477-497.
    [7] 胡云皓, 佟仁冬, 辛凌翔, 刘燕, 王豪杰, 郝力力, 朱良全. 猪链球菌2型的主要毒力因子与先天性免疫逃逸机制[J]. 中国兽医杂志, 2024, 60(10): 98-105. HU YH, TONG RD, XIN LX, LIU Y, WANG HJ, HAO LL, ZHU LQ. Major virulence factors and innate immune evasion mechanisms of Streptococcus suis serotype 2[J]. Chinese Journal of Veterinary Medicine, 2024, 60(10): 98-105(in Chinese).
    [8] 朱僧. 2型猪链球菌突破血脑屏障的相关毒力因子筛选[D]. 长春: 吉林大学硕士学位论文, 2013. ZHU S. Screening of virulence genes contributing to Streptococcus suis type 2 translate across the blood brain barrier[D]. Changchun: Master’s Thesis of Jilin University, 2013(in Chinese).
    [9] LI XD, LI QY, ZHANG ZR, WANG CC, HUO XY, LAI HJ, LU H, LU WJ, QIAN YL, DONG WQ, TAN C, LIU ML. Canagliflozin inhibited the activity of hemolysin and reduced the inflammatory response caused by Streptococcus suis[J]. International Journal of Molecular Sciences, 2023, 24(17): 13074.
    [10] LIU HT, ZHU S, SUN YY, LI N, GU JM, SUN CJ, FENG X, HAN WY, JIANG JX, LEI LC. Selection of potential virulence factors contributing to Streptococcus suis serotype 2 penetration into the blood-brain barrier in an in vitro co-culture model[J]. Journal of Microbiology and Biotechnology, 2017, 27(1): 161-170.
    [11] GOYETTE-DESJARDINS G, AUGER JP, XU JG, SEGURA M, GOTTSCHALK M. Streptococcus suis, an important pig pathogen and emerging zoonotic agent-an update on the worldwide distribution based on serotyping and sequence typing[J]. Emerging Microbes & Infections, 2014, 3(6): e45.
    [12] TAN MF, TAN J, ZHANG FF, LI HQ, JI HY, FANG SP, WU CC, RAO YL, ZENG YB, YANG Q. Exogenous glycogen utilization effects the transcriptome and pathogenicity of Streptococcus suis serotype 2[J]. Frontiers in Cellular and Infection Microbiology, 2022, 12: 938286.
    [13] BRAVO-ALONSO I, MORIN M, ARRIBAS-CARREIRA L, ÁLVAREZ M, PEDRÓN-GINER C, SOLETTO L, SANTOLARIA C, RAMÓN-MAIQUES S, UGARTE M, RODRÍGUEZ-POMBO P, ARIÑO J, MORENO-PELAYO MÁ, PÉREZ B. Pathogenic variants of the coenzyme A biosynthesis-associated enzyme phosphopantothenoylcysteine decarboxylase cause autosomal-recessive dilated cardiomyopathy[J]. Journal of Inherited Metabolic Disease, 2023, 46(2): 261-272.
    [14] JIANG HX, WU T, LIU JN, YU XB, LIU HT, BAO CT, LIU MM, JI YL, FENG X, GU JM, HAN WY, LI N, LEI LC. Caveolae/rafts protect human cerebral microvascular endothelial cells from Streptococcus suis serotype 2α-enolase-mediated injury[J]. Veterinary Microbiology, 2021, 254: 108981.
    [15] 梅纪坤. 胶原酶样蛋白酶促进猪链球菌2型诱发脑膜炎的作用及机制[D]. 长春: 吉林大学硕士学位论文, 2023. MEI JK. Effect and mechanism of collagenase-like protease in promoting meningitis induced by Streptococcus suis type 2[D]. Changchun: Master’s Thesis of Jilin University, 2023(in Chinese).
    [16] LI Q, MA CF, FU Y, HE YN, YU YF, DU DC, YAO HC, LU CP, ZHANG W. Factor H specifically capture novel Factor H-binding proteins of Streptococcus suis and contribute to the virulence of the bacteria[J]. Microbiological Research, 2017, 196: 17-25.
    [17] WANG Y, WANG YX, LI JP, GONG SL, SUN LY, GRENIER D, LI Y. Pdh is involved in the cell division and Normal septation of Streptococcus suis[J]. Microbiological Research, 2019, 228: 126304.
    [18] WU D, CHEN Q, CHEN XJ, HAN F, CHEN Z, WANG Y. The blood-brain barrier: structure, regulation, and drug delivery[J]. Signal Transduction and Targeted Therapy, 2023, 8(1): 217.
    [19] Zheng YY, Sun H, Wang YL, Jin C, Li XY, Pang Y, Ge QW, Wang L, Liu B. CsiR-mediated signal transduction pathway in response to low iron conditions promotes Escherichia coli K1 invasion and penetration of the blood-brain barrier[J]. The Journal of infectious diseases, 2024.
    [20] KOUKI A, HAATAJA S, LOIMARANTA V, PULLIAINEN AT, NILSSON UJ, FINNE J. Identification of a Novel Streptococcal Adhesin p (SadP) protein recognizing galactosyl-α1-4-galactose-containing glycoconjugates convergent evolution of bacterial pathogens to binding of the same host receptor[J]. Journal of Biological Chemistry, 2011, 286(45): 38854-38864.
    [21] QI DK, LIN HY, HU BY, WEI Y. A review on in vitro model of the blood-brain barrier (BBB) based on hCMEC/D3 cells[J]. Journal of Controlled Release, 2023, 358: 78-97.
    [22] JAGTIANI E, YEOLEKAR M, NAIK S, PATRAVALE V. In vitro blood brain barrier models: an overview[J]. Journal of Controlled Release, 2022, 343: 13-30.
    [23] LIU HT, LEI SY, JIA L, XIA XJ, SUN YY, JIANG HX, ZHU RN, LI SG, QU GG, GU JM, SUN CJ, FENG X, HAN WY, LANGFORD PR, LEI LC. Streptococcus suis serotype 2 enolase interaction with host brain microvascular endothelial cells and RPSA-induced apoptosis lead to loss of BBB integrity[J]. Veterinary Research, 2021, 52(1): 30.
    [24] WU T, JIA L, LEI SY, JIANG HX, LIU JN, LI N, LANGFORD PR, LIU HT, LEI LC. Host HSPD1 translocation from mitochondria to the cytoplasm induced by Streptococcus suis serovar 2 enolase mediates apoptosis and loss of blood-brain barrier integrity[J]. Cells, 2022, 11(13): 2071.
    [25] AHISHALI B, KAYA M. Evaluation of blood-brain barrier integrity using vascular permeability markers: Evans blue, sodium fluorescein, albumin-Alexa fluor conjugates, and horseradish peroxidase[M]//Permeability Barrier. New York, NY: Springer US, 2020: 87-103.
    [26] YANG RC, QU XY, XIAO SY, LI L, XU BJ, FU JY, LV YJ, AMJAD N, TAN C, KIM KS, CHEN HC, WANG XR. Meningitic Escherichia coli-induced upregulation of PDGF-B and ICAM-1 aggravates blood-brain barrier disruption and neuroinflammatory response[J]. Journal of Neuroinflammation, 2019, 16(1): 101.
    [27] KIM BJ, HANCOCK BM, BERMUDEZ A, del CID N, REYES E, van SORGE NM, LAUTH X, SMURTHWAITE CA, HILTON BJ, STOTLAND A, BANERJEE A, BUCHANAN J, WOLKOWICZ R, TRAVER D, DORAN KS. Bacterial induction of Snail1 contributes to blood-brain barrier disruption[J]. The Journal of Clinical Investigation, 2015, 125(6): 2473-2483.
    引证文献
    网友评论
    网友评论
    分享到微博
    发 布
引用本文

贾文丹,梅纪坤,王梓萌,李丰阳,雷连成,李娜. 猪链球菌2型PPCDC蛋白对血脑屏障通透性的影响[J]. 微生物学通报, 2025, 52(2): 632-642

复制
分享
文章指标
  • 点击次数:47
  • 下载次数: 66
  • HTML阅读次数: 66
  • 引用次数: 0
历史
  • 收稿日期:2024-11-14
  • 录用日期:2024-12-30
  • 在线发布日期: 2025-02-22
  • 出版日期: 2025-02-20
文章二维码